Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-24T14:30:53.170Z Has data issue: false hasContentIssue false
  • English
  • Français

A Consensus Development Conference on the Practice of Platelet Transfusion in the Netherlands

Published online by Cambridge University Press:  10 March 2009

W. G. van Aken ,
J. A. van der Does ,
C. Dudok de Wit  and
J. J. E. van Everdingen
W. G. van Aken
Affiliation:
Netherlands Red Cross Blood Transfusion Services
J. A. van der Does
Affiliation:
Netherlands Red Cross Blood Transfusion Services
C. Dudok de Wit
Affiliation:
Netherlands Red Cross Blood Transfusion Services
J. J. E. van Everdingen
Affiliation:
National Organization for Quality Assurance in Hospitals
Get access Rights & Permissions [Opens in a new window]

Extract

During the past 5 years, hospitals in several countries have experienced a significant increase in the use of platelet concentrates. In the Netherlands, e.g., the number of donor units of platelet concentrates rose from 59,000 in 1981 to almost 97,000 in 1984 at a cost of 5 million guilders (US $2,800,000) annually. This increased utilization has been attributed to such factors as chemo- and radiotherapy, major surgery, severe trauma, and bone marrow transplantation.

However, there was concern that in a significant number of patients, platelet concentrates are administered for no good reason, that the effect of platelet transfusions is often not adequately controlled, that insufficient care is taken to prevent side effects (notably alloimmunization), and that the quality control applied to platelet suspension is not optimal.

Type
Technology Assessment Reports
Information
International Journal of Technology Assessment in Health Care , Volume 6 , Issue 1 , January 1990 , pp. 163 - 174
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Anonymous. Consensus on blood transfusion therapy in hospitals. Nederlands Tijdschrift voor Geneeskunde, 1983, 127, 1803–07.Google Scholar
Casparie, A. E., & van, Everdingen J. J. E.Consensus development in the Netherlands. International Journal of Technology Assessment in Health Care, 1985, 1, 905–12.CrossRefGoogle ScholarPubMed
Grindon, A. J., Tomasalo, P. S., Bergin, J. J. et al. , The hospital transfusion committee: Guidelines for improving practice. Journal of the American Medical Association, 1985, 253, 540–43.CrossRefGoogle ScholarPubMed
Mielke, C. H.Measurement of bleeding time. International Committee of Hemostasis and Thrombosis. Thrombosis and Hemostasis, 1984, 52, 210–11.Google Scholar
Mielke, C. H. Template bleeding time; technical evaluation and comparison to other methods in normal adults. In Day, H. J. et al. (eds.), Platelet function history. Washington, DC: U.S. Department of Health, Education, and Welfare, 1980.Google Scholar
van, Everdingen J. J. E., Klazinga, N. S., & Casparie, A. F. Blood transfusion policy in Dutch hospitals. International Journal of Health and Quality Assessment, 1988, 16–19.CrossRefGoogle Scholar